Long-term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review

Oronzo Brunetti, Angela Calabrese, Loredana Palermo, Antonio Giovanni Solimando, Antonella Argentiero

Research output: Contribution to journalArticlepeer-review

Abstract

Two phase 3 trials reported a prolonged survival in the third-line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonged stable disease with regorafenib.

Original languageEnglish
Pages (from-to)2379-2383
Number of pages5
JournalClinical Case Reports
Volume7
Issue number12
DOIs
Publication statusPublished - Dec 1 2019

Keywords

  • colorectal cancer
  • long-term survival
  • regorafenib

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Long-term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review'. Together they form a unique fingerprint.

Cite this